Roger Natacha, Zafrani Yaelle, Uzan Catherine, Gouy Sebastien, Rey Annie, Pautier Patricia, Lhommé Catherine, Duvillard Pierre, Castaigne Damienne, Morice Philippe
Service de Chirurgie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France.
Ann Surg Oncol. 2008 Jan;15(1):333-8. doi: 10.1245/s10434-007-9639-6. Epub 2007 Oct 18.
The aim of this study was to determine the influence of the different histological subtypes (serous versus non-serous) on the location of nodal metastases in patients undergoing pelvic and para-aortic lymphadenectomies during the initial management of epithelial ovarian tumors.
We carried out a retrospective analysis of data concerning patients fulfilling the following inclusion criteria: (1) an epithelial ovarian tumor; (2) a complete pelvic and bilateral para-aortic lymphadenectomy up to the level of the left renal vein; (3) surgical procedures including lymphadenectomies performed before adjuvant chemotherapy; and (4) a description of the distribution of positive nodes removed between pelvic and para-aortic areas. Patients were classified into two groups according to the histological subtypes: serous (group 1) and non-serous (group 2) tumors.
Of patients treated between 1989 and 2005, 148 fulfilled the inclusion criteria: 73 had a serous tumor and 75 a non-serous tumor. Positive nodes were observed in 70 (47%) patients-47 (64%) in group 1 and 23 (31%) in group 2 (P < 0.05). But the distribution of involved nodes between pelvic and para-aortic areas in patients with positive nodes was not statistically different between the two groups. In both groups, the most common site for positive nodes in the para-aortic area was the left para-aortic group: 74% in group 1 and 61% in group 2 (NS).
This series suggests that the histological subtype has no impact on the distribution of positive nodes in pelvic and para-aortic areas in patients with epithelial ovarian tumors.
本研究的目的是确定不同组织学亚型(浆液性与非浆液性)对上皮性卵巢肿瘤初始治疗期间接受盆腔和腹主动脉旁淋巴结清扫术患者淋巴结转移部位的影响。
我们对符合以下纳入标准的患者数据进行了回顾性分析:(1)上皮性卵巢肿瘤;(2)完整的盆腔及双侧腹主动脉旁淋巴结清扫术,清扫范围至左肾静脉水平;(3)手术操作包括在辅助化疗前进行的淋巴结清扫术;(4)对盆腔和腹主动脉旁区域切除的阳性淋巴结分布情况的描述。根据组织学亚型将患者分为两组:浆液性肿瘤(第1组)和非浆液性肿瘤(第2组)。
在1989年至2005年接受治疗的患者中,148例符合纳入标准:73例为浆液性肿瘤,75例为非浆液性肿瘤。70例(47%)患者出现阳性淋巴结,第1组47例(64%),第2组23例(31%)(P<0.05)。但两组阳性淋巴结患者中盆腔和腹主动脉旁区域受累淋巴结的分布无统计学差异。在两组中,腹主动脉旁区域阳性淋巴结最常见的部位是左腹主动脉旁组:第1组为74%,第2组为61%(无显著性差异)。
本系列研究表明,组织学亚型对上上皮性卵巢肿瘤患者盆腔和腹主动脉旁区域阳性淋巴结的分布无影响。